{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:37:34Z","timestamp":1790753854184,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Currently, preclinical testing of therapies for hepatoblastoma (HB) is limited to subcutaneous and intrasplenic xenograft models that do not recapitulate the hepatic tumors seen in patients. We hypothesized that injection of HB cell lines into the livers of mice would result in liver tumors that resemble their clinical counterparts. HepG2 and Huh-6 HB cell lines were injected, and tumor growth was monitored with bioluminescence imaging (BLI) and magnetic resonance imaging (MRI). Levels of human \u03b1-fetoprotein (AFP) were monitored in the serum of animals. Immunohistochemical and gene expression analyses were also completed on xenograft tumor samples. BLI signal indicative of tumor growth was seen in 55% of HepG2- and Huh-6-injected animals after a period of four to seven weeks. Increased AFP levels correlated with tumor growth. MRI showed large intrahepatic tumors with active neovascularization. HepG2 and Huh-6 xenografts showed expression of \u03b2-catenin, AFP, and Glypican-3 (GPC3). HepG2 samples displayed a consistent gene expression profile most similar to human HB tumors. Intrahepatic injection of HB cell lines leads to liver tumors in mice with growth patterns and biologic, histologic, and genetic features similar to human HB tumors. This orthotopic xenograft mouse model will enable clinically relevant testing of novel agents for HB.<\/jats:p>","DOI":"10.1038\/s41598-017-17665-8","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T09:37:24Z","timestamp":1513157844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma"],"prefix":"10.1038","volume":"7","author":[{"given":"Sarah E.","family":"Woodfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4345-5825","authenticated-orcid":false,"given":"Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8094-0972","authenticated-orcid":false,"given":"Stephen F.","family":"Sarabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Starosolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Zorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth S.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryana M.","family":"Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Dimiter","family":"Bissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan B.","family":"Ghaghada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Sumazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"L\u00f3pez-Terrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev A.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"17665_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/jhep.2003.50375","volume":"38","author":"A Darbari","year":"2003","unstructured":"Darbari, A., Sabin, K. M., Shapiro, C. N. & Schwarz, K. B. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology \n                           38, 560\u2013566 (2003).","journal-title":"Hepatology"},{"key":"17665_CR2","first-page":"293","volume":"3","author":"E Hiyama","year":"2014","unstructured":"Hiyama, E. Pediatric hepatoblastoma: diagnosis and treatment. Translational Pediatrics \n                           3, 293\u2013299 (2014).","journal-title":"Translational Pediatrics"},{"key":"17665_CR3","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/pbc.22088","volume":"53","author":"RL Meyers","year":"2009","unstructured":"Meyers, R. L. et al. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children\u2019s Oncology Group. Pediatr. Blood Cancer \n                           53, 1016\u20131022 (2009).","journal-title":"Pediatr. Blood Cancer"},{"key":"17665_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10147-013-0616-8","volume":"18","author":"K Watanabe","year":"2013","unstructured":"Watanabe, K. Current chemotherapeutic approaches for hepatoblastoma. Int J Clin Oncol \n                           18, 955\u2013961 (2013).","journal-title":"Int J Clin Oncol"},{"key":"17665_CR5","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1097\/MPH.0b013e31821f0eaf","volume":"33","author":"P Sivaprakasam","year":"2011","unstructured":"Sivaprakasam, P., Gupta, A. A., Greenberg, M. L., Capra, M. & Nathan, P. C. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin. J Pediatr Hematol Oncol \n                           33, e226\u201330 (2011).","journal-title":"J Pediatr Hematol Oncol"},{"key":"17665_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros, J. et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncology \n                           14, 834\u2013842 (2013).","journal-title":"Lancet Oncology"},{"key":"17665_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","volume":"184","author":"X Chen","year":"2014","unstructured":"Chen, X. & Calvisi, D. F. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. The American Journal of Pathology \n                           184, 912\u2013923 (2014).","journal-title":"The American Journal of Pathology"},{"key":"17665_CR8","first-page":"809","volume":"74","author":"T Pietsch","year":"1996","unstructured":"Pietsch, T. et al. Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma. Lab Invest \n                           74, 809\u2013818 (1996).","journal-title":"Lab Invest"},{"key":"17665_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jhep.2006.03.018","volume":"45","author":"JM Schnater","year":"2006","unstructured":"Schnater, J. M. et al. Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice. Journal of Hepatology \n                           45, 377\u2013386 (2006).","journal-title":"Journal of Hepatology"},{"key":"17665_CR10","doi-asserted-by":"publisher","first-page":"e23419","DOI":"10.1371\/journal.pone.0023419","volume":"6","author":"V Ellerkamp","year":"2011","unstructured":"Ellerkamp, V. et al. Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD\/LtSz-scid IL2Rgammanull mice. PLoS ONE \n                           6, e23419 (2011).","journal-title":"PLoS ONE"},{"key":"17665_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0006-291X(83)91037-9","volume":"110","author":"M Tanaka","year":"1983","unstructured":"Tanaka, M. et al. Production of fibronectin by HUH6 C15 cell line established from a human hepatoblastoma. Biochem Biophys Res Commun \n                           110, 837\u2013841 (1983).","journal-title":"Biochem Biophys Res Commun"},{"key":"17665_CR12","first-page":"1","volume":"67","author":"I Doi","year":"1976","unstructured":"Doi, I. Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. Gan \n                           67, 1\u201310 (1976).","journal-title":"Gan"},{"key":"17665_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s11307-009-0213-4","volume":"11","author":"L-C Ong","year":"2009","unstructured":"Ong, L.-C. et al. Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model. Mol Imaging Biol \n                           11, 334\u2013342 (2009).","journal-title":"Mol Imaging Biol"},{"key":"17665_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jhep.2016.04.009","volume":"65","author":"B Bissig-Choisat","year":"2016","unstructured":"Bissig-Choisat, B. et al. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. Journal of Hepatology \n                           65, 325\u2013333 (2016).","journal-title":"Journal of Hepatology"},{"key":"17665_CR15","first-page":"36045","volume":"6","author":"M Wu","year":"2016","unstructured":"Wu, M. et al. HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2. Nature Publishing Group \n                           6, 36045 (2016).","journal-title":"Nature Publishing Group"},{"key":"17665_CR16","doi-asserted-by":"publisher","unstructured":"Ahmed, S. U. et al. Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice. J Vis Exp e50544, https:\/\/doi.org\/10.3791\/50544 (2013).","DOI":"10.3791\/50544"},{"key":"#cr-split#-17665_CR17.1","unstructured":"Roebuck, D. J. et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol"},{"key":"#cr-split#-17665_CR17.2","unstructured":"37, 123-32- quiz 249-50 (2007)."},{"key":"17665_CR18","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","volume":"18","author":"JA Ortega","year":"2000","unstructured":"Ortega, J. A. et al. Randomized comparison of cisplatin\/vincristine\/fluorouracil and cisplatin\/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children\u2019s Cancer Group and the Pediatric Oncology Group. Journal of Clinical Oncology \n                           18, 2665\u20132675 (2000).","journal-title":"Journal of Clinical Oncology"},{"key":"17665_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1203\/01.pdr.0000232789.86632.91","volume":"60","author":"M Browne","year":"2006","unstructured":"Browne, M. et al. Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model. Pediatr Res \n                           60, 282\u2013287 (2006).","journal-title":"Pediatr Res"},{"key":"17665_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/modpathol.2014.27","volume":"27","author":"D Lopez-Terrada","year":"2014","unstructured":"Lopez-Terrada, D. et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol \n                           27, 472\u2013491 (2014).","journal-title":"Mod Pathol"},{"key":"17665_CR21","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.ejca.2011.10.019","volume":"48","author":"R Purcell","year":"2012","unstructured":"Purcell, R. et al. Potential biomarkers for hepatoblastoma: results from the SIOPEL-3 study. European Journal of Cancer \n                           48, 1853\u20131859 (2012).","journal-title":"European Journal of Cancer"},{"key":"17665_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.humpath.2007.06.006","volume":"39","author":"DL Zynger","year":"2008","unstructured":"Zynger, D. L. et al. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Hum Pathol \n                           39, 224\u2013230 (2008).","journal-title":"Hum Pathol"},{"key":"17665_CR23","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","volume":"61","author":"M Eichenmuller","year":"2014","unstructured":"Eichenmuller, M. et al. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. Journal of Hepatology \n                           61, 1312\u20131320 (2014).","journal-title":"Journal of Hepatology"},{"key":"17665_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH804>3.0.CO;2-R","volume":"193","author":"WS Park","year":"2001","unstructured":"Park, W. S. et al. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol \n                           193, 483\u2013490 (2001).","journal-title":"J Pathol"},{"key":"17665_CR25","first-page":"269","volume":"59","author":"A Koch","year":"1999","unstructured":"Koch, A. et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Research \n                           59, 269\u2013273 (1999).","journal-title":"Cancer Research"},{"key":"17665_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3748\/wjg.v21.i1.311","volume":"21","author":"D Cevik","year":"2015","unstructured":"Cevik, D., Yildiz, G. & Ozturk, M. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations. World Journal of Gastroenterology \n                           21, 311\u2013317 (2015).","journal-title":"World Journal of Gastroenterology"},{"key":"17665_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo, S. et al. Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell \n                           14, 471\u2013484 (2008).","journal-title":"Cancer Cell"},{"key":"17665_CR28","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/hep.28621","volume":"64","author":"D Nicolle","year":"2016","unstructured":"Nicolle, D. et al. Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management. Hepatology \n                           64, 1121\u20131135 (2016).","journal-title":"Hepatology"},{"key":"17665_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ygeno.2010.08.003","volume":"96","author":"Y Yu","year":"2010","unstructured":"Yu, Y. et al. A comparative analysis of liver transcriptome suggests divergent liver function among human, mouse and rat. Genomics \n                           96, 281\u2013289 (2010).","journal-title":"Genomics"},{"key":"17665_CR30","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng2047","volume":"39","author":"DT Odom","year":"2007","unstructured":"Odom, D. T. et al. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nature Genetics \n                           39, 730\u2013732 (2007).","journal-title":"Nature Genetics"},{"key":"17665_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","volume":"138","author":"AK Mitra","year":"2015","unstructured":"Mitra, A. K. et al. In vivo tumor growth of high-grade serous ovarian cancer cell lines. Gynecologic Oncology \n                           138, 372\u2013377 (2015).","journal-title":"Gynecologic Oncology"},{"key":"17665_CR32","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1073\/pnas.0502887102","volume":"102","author":"K Camphausen","year":"2005","unstructured":"Camphausen, K. et al. Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions. Proc. Natl. Acad. Sci. USA \n                           102, 8287\u20138292 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"17665_CR33","first-page":"92","volume-title":"European Journal of Cancer","author":"P Czauderna","year":"2016","unstructured":"Czauderna, P. et al. TheChildren\u2019s Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. European Journal of Cancer \n                           52, 92\u2013101 (2016)."},{"key":"17665_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers, R. L. et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration. Lancet Oncology \n                           18, 122\u2013131 (2017).","journal-title":"Lancet Oncology"},{"key":"17665_CR35","doi-asserted-by":"publisher","first-page":"e7628","DOI":"10.1371\/journal.pone.0007628","volume":"4","author":"KB Ghaghada","year":"2009","unstructured":"Ghaghada, K. B. et al. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS ONE \n                           4, e7628 (2009).","journal-title":"PLoS ONE"},{"key":"17665_CR36","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov, A. et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging \n                           30, 1323\u20131341 (2012).","journal-title":"Magn Reson Imaging"},{"key":"17665_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28888","author":"P Sumazin","year":"2016","unstructured":"Sumazin, P. et al. Genomic Analysis of Hepatoblastoma Identifies Distinct Molecular and Prognostic Subgroups. Hepatology. https:\/\/doi.org\/10.1002\/hep.28888 (2016).","journal-title":"Hepatology"},{"key":"17665_CR38","first-page":"15","volume-title":"Bioinformatics","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics \n                           29, 15\u201321 (2013)."},{"key":"17665_CR39","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc \n                           7, 562\u2013578 (2012).","journal-title":"Nat Protoc"},{"key":"17665_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.009","author":"B Bissig-Choisat","year":"2016","unstructured":"Bissig-Choisat, B. et al. Novel Patient-Derived Xenograft and Cell Line Models for Therapeutic Testing of Pediatric Liver Cancer. Journal of Hepatology. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.009 (2016).","journal-title":"Journal of Hepatology"},{"key":"17665_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics \n                           12, 323 (2011).","journal-title":"BMC Bioinformatics"},{"key":"17665_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat Methods \n                           9, 357\u2013359 (2012).","journal-title":"Nat Methods"},{"key":"17665_CR43","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA \n                           102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17665-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17665-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17665-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T16:46:20Z","timestamp":1671813980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17665-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["17665"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-17665-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"assertion":[{"value":"31 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17751"}}